Diseases of the Teats and Udder

Rebhun's Diseases of Dairy Cattle

Volumn , Issue , 2008, Pages 327-394

  George, Lisle W ^a   Divers, Thomas J ^b   Ducharme, Norm ^b   Welcome, Frank L ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882542698     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-141603137-6.50011-9     Document Type: Chapter

References (116)

1. Anderson KL, Smith AR, Gustafsson BK, et al. Diagnosis and treatment of acute mastitis in a large dairy herd. J Am Vet Med Assoc 1982, 181:690-693.
2. Anderson KL, Walker RL Sources of Prototheca spp in a dairy herd environment. J Am Vet Med Assoc 1988, 193:553-556.
3. Arighi M, Ducharme NG, Honey FD, et al. Invasive teat surgery in dairy cattle. Part II. Long-term follow-up and complications. Can Vet J 1987, 28:737-763.
4. Barkema HW, Schukken YH, Zadoks RN Invited review: the role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Staphylococcus aureus mastitis. J Dairy Sci 2006, 89:1877-1895.
5. Bayoumi FA, Farver TB, Bushnell B, et al. Enzootic mycoplasmal mastitis in a large dairy during an eight-year period. J Am Vet Med Assoc 1988, 192:905-909.
6. Berry EA, Johnston WT, Hillerton JE Prophylactic effects of two selective dry cow strategies accounting for interdependence of Quarter. J Dairy Sci 2003, 86:3812-3919.
7. Bleul UT, Schwantag SC, Bachofner C, et al. Milk flow and udder health in cows after treatment of covered teat injuries via theloresectoscopy: 52 cases (2000-2002). J Am Vet Med Assoc 2005, 226:1119-1123.
8. Bloomquist C, Davidson JN Zearalenone toxicosis in prepubertal dairy heifers. J Am Vet Med Assoc 1982, 180:164-165.
9. Bowman GL, Hueston WD, Boner GJ, et al. Serratia liquefaciens mastitis in a dairy herd. J Am Vet Med Assoc 1986, 189:913-915.
10. Brka M, Reinsch N, Kalm E. Frequency and heritability of supernumerary teats in German Simmental and German Brown Swiss cows. J Dairy Sci 2002, 85:1881-1886.
11. Burvenich C, Van Merris V, Mehrzad J, et al. Severity of E. coli mastitis is mainly determined by cow factors. Vet Res 2003, 34:521-564.
12. Bushnell RB Mycoplasma mastitis. Vet Clin North Am (Large Anim Pract) 1984, 6:301-312.
13. Bushnell RB The importance of hygienic procedures in controlling mastitis. Vet Clin North Am (Large Anim Pract) 1984, 6:361-370.
14. Butler JA, Sickles SA, Johanns CJ, et al. Pasteurization of discard Mycoplasma mastitis milk used to feed calves: thermal effects on various Mycoplasma. J Dairy Sci 2000, 83:2285-2288.
15. Chester ST, Moseley WM Extended ceftiofur therapy for treatment of experimentally-induced Streptococcus uberis mastitis in lactating dairy cattle. J Dairy Sci 2004, 87:3322-3329.
16. Constable PD, Morin DE Treatment of clinical mastitis using antimicrobial susceptibility profiles for treatment decisions. Vet Clin North Am Food Anim Pract 2003, 19:139-155.
17. Couture Y, Mulon PY Procedures and surgeries of the teat. Vet Clin North Am Food Anim Pract 2005, 21:173-204.
18. Cullor JS The Escherichia coli J5 vaccine: investigating a new tool to combat coliform mastitis. Vet Med August 1991, 836-844.
19. Deluyker HA, VanOye SN, Boucher JF Factors affecting cure and somatic cell count after pirlimycin treatment of subclinical mastitis in lactating cows. J Dairy Sci 2005, 88:604-614.
20. Denamiel G, Llorente P, Carabella M, et al. Anti-microbial susceptibility of Streptococcus spp. isolated from bovine mastitis in Argentina. J Vet Med B Infect Dis Vet Public Health 2005, 52:125-128.
21. Ducharme NG, Horney FD, Baird JD, et al. Invasive teat surgery in dairy cattle. Part I. Surgical procedures and classification of lesions. Can Vet J 1987, 28:757-762.
22. Erskine RJ, Bartlett PC, Johnson GL, et al. Intramuscular administration of ceftiofur sodium versus intramammary infusion of penicillin/novobiocin for treatment of Streptococcus agalactiae mastitis in dairy cows. J Am Vet Med Assoc 1996, 205:258-260.
23. Erskine RJ, Bartlett PC, VanLente JL, et al. Efficacy of systemic ceftiofur as a therapy for severe clinical mastitis in dairy cattle. J Dairy Sci 2002, 85:2571-2575.
24. Erskine RJ, Eberhart RJ, Hutchinson LJ, et al. Incidence and types of clinical mastitis in dairy herds with high and low somatic cell counts. J Am Vet Med Assoc 1988, 192:761-765.
25. Erskine RJ, Tyler JW, Riddell MG, et al. Theory, use, and realities of efficacy and food safety of antimicrobial treatment of acute coliform mastitis. J Am Vet Med Assoc 1991, 198:980-984.
26. Erskine RJ, Unflat JG, Eberhart RJ, et al. Pseudomonas mastitis: difficulties in detection and elimination from contaminated wash-water systems. J Am Vet Med Assoc 1987, 191:811-815.
27. Erskine RJ, Wilson RC, Tyler JW, et al. Ceftiofur distribution in serum and milk from clinically normal cows and cows with experimental Escherichia coli-induced mastitis. Am J Vet Res 1995, 56:481-485.
28. Foret CJ, Corbellini C, Young S, et al. Efficacy of two iodine teat dips based on reduction of naturally occurring new intramammary infections. J Dairy Sci 2005, 88:426-432.
29. Fox LK, Kirk JH, Britten A. Mycoplasma mastitis: a review of transmission and control. J Vet Med B Infect Dis Vet Public Health 2005, 52:153-160.
30. Galton DM, Petersson LG, Erb HN Milk iodine residues in herds practicing iodophor premilking teat disinfection. J Dairy Sci 1986, 69:267-271.
31. Galton DM, Peterson LG, Merrill WG Evaluation of udder preparations on intramammary infections. J Dairy Sci 1988, 71:1417-1421.
32. Gibbons-Burgener S, Kaneene JB, Lloyd JW, et al. Reliability of three bulk tank antimicrobial residue detection assays used to test individual milk samples from cows with mild clinical mastitis. Am J Vet Res 2001, 62:1716-1720.
33. Godden S, Rapnicki P, Stewart S, et al. Effectiveness of an internal teat seal in the prevention of new intramammary infections during the dry and early-lactation periods in dairy cows when used with a dry cow intramammary antibiotic. J Dairy Sci 2003, 86:3899-3911.
34. Goff JP Major advances in our understanding of nutritional influences on bovine health. J Dairy Sci 2006, 89:1292-1301.
35. González RN, Cullor JS, Jasper DE, et al. Prevention of clinical coliform mastitis in dairy cows by a mutant Escherichia coli vaccine. Can J Vet Res 1989, 53:301-305.
36. González RN, Sears PM, Merrill RA, et al. Mastitis due to Mycoplasma in the state of New York during the period 1972-1990. Cornell Vet 1992, 82:29-40.
37. Green MJ, Green LE, Bradley AJ, et al. Prevalence and associations between bacterial isolates from dry mammary glands of dairy cows. Vet Rec 2005, 156:71-77.
38. Grohn YT, Gonzalez RN, Wilson DJ, et al. Effect of pathogen-specific clinical mastitis on herd life in two New York State Dairy herds. Prev Vet Med 2005, 71:105-125.
39. Hallberg JW, Wachowski M, Moseley WM, et al. Efficacy of intramammary infusion of ceftiofur hydrochloride at drying off for treatment and prevention of bovine mastitis during the nonlactating period. Vet Ther 2006, 7:35-42.
40. Hemmatzadeh F, Fatemi A, Amini F. Therapeutic effects of fig tree latex on bovine papillomatosis. J Vet Med B Infect Dis Vet Public Health 2003, 50:473-476.
41. Hill AW, Shears AL, Hibbitt KG The pathogenesis of experimental Escherichia coli mastitis in newly calved dairy cows. Res Vet Sci 1979, 26:97-101.
42. Hillerton JE, Berry EA The management and treatment of environmental streptococcal mastitis. Vet Clin North Am Food Anim Pract 2003, 19:157-169.
43. Hillerton JE, Bramley AJ, Staker RT, et al. Patterns of intramammary infection and clinical mastitis over a 5 year period in a closely monitored herd applying mastitic control measures. J Dairy Res 1995, 62:39-50.
44. Hillerton JE, Kliem KE Effective treatment of Streptococcus uberis clinical mastitis to minimize the use of antibiotics. J Dairy Sci 2002, 85:1009-1014.
45. Hoe FG, Ruegg PL Relationship between antimicrobial susceptibility of clinical mastitis pathogens and treatment outcome in cows. J Am Vet Med Assoc 2005, 227:1461-1468.
46. Hoeben D, Burvenich C, Heyneman R. Influence of antimicrobial agents on bactericidal activity of bovine milk polymorphonuclear leukocytes. Vet Immunol Immunopathol 1997, 56:271-282.
47. Hogan J, Smith KL Coliform mastitis. Vet Res 2003, 34:507-519.
48. Hortet P, Seegers H. Calculated milk production loss associated with elevated somatic cell counts in dairy cows: review and critical discussion. Vet Res 1998, 29:497-510.
49. Janett F, Stauber N, Schraner E, et al. Bovine herpes mammillitis: clinical symptoms and serologic course. Schweiz Arch Tierheilkd 2000, 142:375-380.
50. Jarp J, Bugge HP, Larsen S. Clinical trial of three therapeutic regimens for bovine mastitis. Vet Rec 1989, 124:630-634.
51. Jones GF, Ward GE Evaluation of systemic administration of gentamicin for treatment of coliform mastitis in cows. J Am Vet Med Assoc 1990, 197:731-735.
52. Jones TO Correct use of intramammary treatments at drying off. Vet Rec 2004, 154:799.
53. Kang JH, Jin JH, Kondo F. False-positive outcome and drug residue in milk samples over withdrawal times. J Dairy Sci 2005, 88:908-913.
54. Knight AP Plants affecting the mammary gland. A guide to plant poisoning in North America 2004, Teton NewMedia, IVIS, Ithaca, NY.
55. Kristula MA, Rogers W, Hogan JS, et al. Comparison of bacteria populations in clean and recycled sand used for bedding in dairy facilities. J Dairy Sci 2005, 88:4317-4325.
56. LeBlanc SJ, Lissemore KD, Kelton DF, et al. Major advances in disease prevention in dairy cattle. J Dairy Sci 2006, 89:1267-1271.
57. Leininger DJ, Roberson JR, Elvinger F, et al. Evaluation of frequent milkout for treatment of cows with experimentally induced Escherichia coli mastitis. J Am Vet Med Assoc 2003, 222:63-66.
58. Letchworth GJ, Carmichael LE Local tissue temperature: a critical factor in the pathogenesis of bovid herpesvirus 2. Infect Immun 1984, 43:1072-1079.
59. Makovec JA, Ruegg PL Characteristics of milk samples submitted for microbiological examination in Wisconsin from 1994 to 2001. J Dairy Sci 2003, 86:3466-3472.
60. McDermott MP, Erb HN, Natzke RP Predictability by somatic cell counts related to prevalence of intramammary infection within herds. J Dairy Sci 1982, 65:1535-1539.
61. McDonald JS, Anderson AJ Experimental intramammary infection of the dairy cow with Escherichia coli during the nonlactating period. Am J Vet Res 1981, 42:229-331.
62. McDougall S. Efficacy of two antibiotic treatments in curing clinical and subclinical mastitis in lactating dairy cows. N Z Vet J 1998, 46:226-232.
63. McDougall S. Intramammary treatment of clinical mastitis of dairy cows with a combination of lincomycin and neomycin, or penicillin and dihydrostreptomycin. N A Vet J 2003, 51:111-116.
64. McLennan MW, Kelly WR, O'Boyle D. Pseudomonas mastitis in a dairy herd. Aust Vet J 1997, 75:790-792.
65. Middleton JR, Hebert VR, Fox LK, et al. Elimination kinetics of chlorhexidine in milk following intramammary infusion to stop lactation in mastitic mammary gland quarters of cows. J Am Vet Med Assoc 2003, 222:1746-1749.
66. Middleton JR, Timms LL, Bader GR, et al. Effect of prepartum intramammary treatment with pirlimycin hydrochloride on prevalence of early first-lactation mastitis in dairy heifers. J Am Vet Med Assoc 2005, 227:1969-1974.
67. Milne MH, Biggs AM, Barrett DC, et al. Treatment of persistent intramammary infections with Streptococcus uberis in dairy cows. Vet Rec 2005, 157:245-250.
68. Morin DE, Shanks RD, McCoy GC Comparison of antibiotic administration in conjunction with supportive measures versus supportive measures alone for treatment of dairy cows with clinical mastitis. J Am Vet Med Assoc 1998, 213:676-684.
69. Nickerson SC Immune mechanisms of the bovine udder: an overview. J Am Vet Med Assoc 1985, 187:41-45.
70. Nickerson SC Resistance mechanisms of the bovine udder: new implications for mastitis control at the teat end. J Am Vet Med Assoc 1987, 191:1484-1488.
71. Nickerson SC, Owens WE Staphylococcus aureus mastitis: reasons for treatment failures and therapeutic approaches for control. Agri-Practice 1993, 14:18-23.
72. Nickerson SC, Pankey JW Cytologic observations of the bovine teat end. Am J Vet Res 1983, 44:1433-1441.
73. Ogawa T, Tomita Y, Okada M, et al. Broad-spectrum detection of papillomaviruses in bovine teat papillomas and healthy teat skin. J Gen Virol 2004, 85:2191-2197.
74. Oliver SP, Almeida RA, Gillespie BE, et al. Efficacy of extended pirlimycin therapy for treatment of experimentally induced Streptococcus uberis intramammary infections in lactating dairy cows. Vet Ther 2003, 4:299-308.
75. Oliver SP, Almeida RA, Gillespie BE, et al: Efficacy of extended ceftiofur intramammary therapy for treatment of subclinical mastitis in lactating dairy cows. J Dairy Sci 87:2393-2400.
76. Oliver SP, Gillespie BE, Ivey SJ, et al. Influence of prepartum pirlimycin hydrochloride or penicillin-novobiocin therapy on mastitis in heifers during early lactation. J Dairy Sci 2004, 87:1727-1731.
77. Oliver SP, Matthews KR Analytical review of new teat dip efficacy claims. Bov Proc 1994, 26:79-83.
78. Owens WE Evaluation of antibiotics for induction of L-forms from Staphylococcus aureus strains isolated from bovine mastitis. J Clin Microbiol 1988, 26:2187-2190.
79. Owens WE, Ray CH, Watts JL, et al. Comparison of success of antibiotic therapy during lactation and results of antimicrobial susceptibility tests for bovine mastitis. J Dairy Sci 1997, 80:313-317.
80. Owens WE, Watts JL, Boddie RL, et al. Antibiotic treatment of mastitis: comparison of intramammary and intramammary plus intramuscular therapies. J Dairy Sci 1988, 71:3143-3147.
81. Parkinson TJ, Vermunt JJ, Merrall M. Comparative efficacy of three dry-cow antibiotic formulations in spring-calving New Zealand dairy cows. N Z Vet J 2000, 48:129-135.
82. Polk C. Cows, ground surface potentials and earth resistance. Bioelectromagnetics 2001, 22:7-18.
83. Povey RC, Osborne A. Mammary gland neoplasia in the cow. Pathol Vet 1969, 6:502-512.
84. Power E. Gangrenous mastitis in dairy herds. Vet Rec 2003, 153:791-792.
85. Querengasser J, Geishauser K, Querengasser K, et al. Comparative evaluation of SIMPL silicone implants and NIT natural teat inserts to keep the teat canal patent after surgery. J Dairy Sci 2002, 85:1732-1737.
86. Reed DE, Langpap MS, Anson MS Characterization of herpesviruses isolated from lactating dairy cows with mammary pustular dermatitis. Am J Vet Res 1977, 38:1631-1634.
87. Roberson JR, Warnick LD, Moore G. Mild to moderate clinical mastitis: efficacy of intramammary amoxicillin, frequent milk-out, a combined intramammary amoxicillin, and frequent milk-out treatment versus no treatment. J Dairy Sci 2004, 87:392-583.
88. Robert A, Seegers H, Bareille N. Incidence of intramammary infections during the dry period without or with antibiotic treatment in dairy cows-a quantitative analysis of published data. Vet Res 2006, 37:25-48.
89. Ruegg PL Investigation of mastitis problems on farms. Vet Clin North Am Food Anim Pract 2003, 19:47-74.
90. Sargeant JM, Scott HM, Leslie KE, et al. Clinical mastitis in dairy cattle in Ontario: frequency of occurrence and bacteriological isolates. Can Vet J 1998, 39:33-38.
91. Sears PM, Fettinger M, Marsh-Salin J. Isolation of L-form variants after antibiotic treatment in Staphylococcus aureus bovine mastitis. J Am Vet Med Assoc 1987, 191:681-684.
92. Sears PM, González RN, Wilson DJ, et al. Procedures for mastitis diagnosis and control. Vet Clin North Am (Food Anim Pract) 1993, 9:445-468.
93. Sears PM, Smith BS, English PB, et al. Shedding pattern of Staphylococcus aureus from bovine intramammary infections. J Dairy Sci 1990, 73:2785-2789.
94. Serieys F, Raquet Y, Goby L, et al. Comparative efficacy of local and systemic antibiotic treatment in lactating cows with clinical mastitis. J Dairy Sci 2005, 88:93-99.
95. Shim EH, Shanks RD, Morin DE, et al. Milk loss and treatment costs associated with two treatment protocols for clinical mastitis in dairy cows. J Dairy Sci 2004, 87:2702-2708.
96. Smith GW, Gehring R, Craigmill AL, et al. Extralabel intramammary use of drugs in dairy cattle. J Am Vet Med Assoc 2005, 226:1994-1996.
97. Smith GW, Lyman RL, Anderson KL Efficacy of vaccination and antimicrobial treatment to eliminate chronic intramammary Staphylococcus aureus infections in dairy cattle. J Am Vet Med Assoc 2006, 228:422-425.
98. Sol J, Sampimon OC, Snoep JJ, et al. Factors associated with bacteriological cure during lactation after therapy for subclinical mastitis caused by Staphylococcus aureus. J Dairy Sci 1997, 80:2803-2808.
99. Taponen S, Simojoki H, Haveri M, et al. Clinical characteristics and persistence of bovine mastitis caused by different species of coagulase-negative staphylococci identified with API or AFLP. Vet Microbiol 2006, 115:199-207.
100. Thornsberry C, Marler JK, Watts JL, et al. Activity of pirlimycin against pathogens from cows with mastitis and recommendations for disk diffusion tests. Antimicrob Agents Chemother 1993, 37:1122-1126.
101. Tyler JW, Wilson RC, Dowling P. Treatment of subclinical mastitis. Vet Clin North Am (Food Anim Pract) 1992, 8:17-28.
102. Waage S, Mork T, Roros A, et al. Bacteria associated with clinical mastitis in dairy heifers. J Dairy Sci 1999, 82:712-719.
103. Waage S, Odegaard SA, Lund A, et al. Case-control study of risk factors for clinical mastitis in postpartum dairy heifers. J Dairy Sci 2001, 84:392-399.
104. Warnick LD, Nydam D, Maciel A, et al. Udder cleft dermatitis and sarcoptic mange in a dairy herd. J Am Vet Med Assoc 2002, 221:273-276.
105. Wenz JR, Barrington GM, Garry FB, et al. Bacteremia associated with naturally occurring acute coliform mastitis in dairy cows. J Am Vet Med Assoc 2001, 219:976-981.
106. Wenz JR, Garry FB, Lombard JE, et al. Short communication: efficacy of paternal ceftiofur for treatment of systemically mild clinical mastitis in dairy cattle. J Dairy Sci 2005, 88:3496-3499.
107. Wilson DJ, Gonzalez RN, Case KL, et al. Comparison of seven antibiotic treatments with no treatment for bacteriological efficacy against bovine mastitis pathogens. J Dairy Sci 1999, 82:1664-1670.
108. Wilson DJ, Kirk JH, Walker RD, et al. Serratia marcescens mastitis in a dairy herd. J Am Vet Med Assoc 1990, 196:1102-1105.
109. Woolford MW, Williamson JH, Day AM, et al. The prophylactic effect of a teat sealer on bovine mastitis during the dry period and the following lactation. N Z Vet J 1998, 46:12-19.
110. Wraight MD A comparative efficacy trial between cefuroxime and cloxacillin as intramammary treatments for clinical mastitis in lactating cows on commercial dairy farms. N Z Vet J 2003, 51:26-32.
111. Wraight MD A comparative field trial of cephalonium and cloxacillin for dry cow therapy for mastitis in Australian dairy cows. Aust Vet J 2005, 83:103-104.
112. Yamagata M, Goodger WJ, Weaver L, et al. The economic benefit of treating subclinical Streptococcus agalactiae mastitis in lactating cows. J Am Vet Med Assoc 1987, 191:1556-1561.
113. Younis A, Krifucks O, Fleminger G, et al. Staphylococcus aures leucocidin, a virulence factor in bovine mastitis. J Dairy Res 2005, 72:188-194.
114. Zadoks RN, Allore HG, Barkema HW, et al. Cow and quarter level risk factors for Streptococcus uberis and Staphylococcus aureus mastitis. J Dairy Sci 2001, 84:2649-2663.
115. Zdanowicz M, Shelford JA, Tucker CB, et al. Bacterial populations on teat ends of dairy cows housed in free stalls and bedded with either sand or sawdust. J Dairy Sci 2004, 87:1694-1701.
116. Ziv G. Treatment of peracute and acute mastitis. Vet Clin North Am (Food Anim Pract) 1992, 8:1-15.